Sarcoma
776
125
167
398
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
119 trials with published results (15%)
Research Maturity
398 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.6%
90 terminated out of 776 trials
81.6%
-5.0% vs benchmark
6%
46 trials in Phase 3/4
30%
119 of 398 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 398 completed trials
Clinical Trials (776)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Distance-Based Exercise to Preserve Function and Prevent Disability
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
HTL0039732 in Participants With Advanced Solid Tumours
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors
A First-in-Human Study of ¹⁷⁷Lu-HX02 in Sarcoma Patients
DESTINY-PANTUMOUR04
Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer
A Study of CRD3874-SI in People With Solid Tumors
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
Biomarkers of Resiliency In Childhood Cancer Surgery
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Bevacizumab/Doxorubicin/Radiation for Sarcoma